Relationship of the use of adjunctive pharmacological agents to symptoms and level of function in schizophrenia

American Journal of Psychiatry

Volumn 159, Issue 6, 2002, Pages 1035-1043

  Buchanan, Robert W ^a   Kreyenbuhl, Julie ^a   Zito, Julie M ^a   Lehman, Anthony ^a  

^a MARYLAND PSYCHIATRIC RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIPARKINSON AGENT; ANXIOLYTIC AGENT; NEUROLEPTIC AGENT;

ADULT; ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; DEMOGRAPHY; ETHNOLOGY; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MEDICAL RECORD; OUTCOMES RESEARCH; OUTPATIENT; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHIZOPHRENIA; SIDE EFFECT; SYMPTOM;

ADULT; AMBULATORY CARE; ANTI-ANXIETY AGENTS; ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS; ANTIPARKINSON AGENTS; ANTIPSYCHOTIC AGENTS; CROSS-SECTIONAL STUDIES; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; SEVERITY OF ILLNESS INDEX;

EID: 0036268610     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.159.6.1035     Document Type: Article

References (17)

1. Adjunctive treatments in schizophrenia: Pharmacotherapies and electroconvulsive therapy
2. At issue: Translating research into practice: The schizophrenia Patient Outcomes Research Team (PORT) treatment recommendations
3. Patterns of usual care for schizophrenia: Initial results from the schizophrenia Patient Outcomes Research Team (PORT) client survey
4. The well-being of chronic mental patients: Assessing their quality of life
5. Alcohol and drug CAGE screeners for pregnant, low-income women: The California Perinatal Needs Assessment
6. SCL-90: An outpatient psychiatric rating scale-preliminary report
7. Clozapine for the treatment-resistant schizophrenic: A double-blind comparison with chlorpromazine
8. Risperidone in the treatment of schizophrenia
9. Risperidone in the treatment of patients with chronic schizophrenia: A multi-national, multi-centre, double-blind, parallel-group study versus haloperidol
10. Positive and negative symptom response to clozapine in schizophrenic patients with and without the deficit syndrome
11. Confirmation of the dimensional structure of the SCL-90: A study in construct validation
12. The efficiency of simulation-based multiple comparisons
13. Clozapine: Efficacy and safety
14. Issues in the psychiatric treatment of African Americans
15. What are the functional consequences of neurocognitive deficits in schizophrenia?
16. Should schizophrenia be treated as a neurocognitive disorder?